Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Phage Pharm logo — Phage Pharm is a professional enterprise in the industrializ...

Phage Pharm

Phage Pharm is a professional enterprise in the industrialization of bacteriophages.

Founded 2017 Series B Total: $90.00M Biotechnology, Manufacturing +1

General Information

Company Name Phage Pharm
Founded Year 2017
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Phage Pharm. To contact Phage Pharm, visit phageseeker.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Phage Pharm

Phage Pharm is a professional enterprise in the industrialization of bacteriophages, specializing in biotechnology, manufacturing, and pharmaceuticals. The company was founded in 2017 and has been making significant strides in the industry. With a focus on harnessing the potential of bacteriophages, Phage Pharm has attracted substantial investment, including a remarkable CNY90.00M Series B investment on 01 March 2023. This infusion of capital came from Cenova and Morningside Venture Investments, demonstrating confidence in the company's vision and potential for growth. As the company continues to develop innovative solutions and make advancements in biotechnology, its ability to secure substantial investments further solidifies its position as a key player in the industry.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY90.00M 2
Cenova
Cenova, Morningside Venture Investments
01 Mar 2023

Phage Pharm Alternatives & Competitors

View All Alternatives
Phage Pharm vs
Omnilytics Inc
Omnilytics Inc

A Biotech Phage Development & Production Company Focused on Changing the Way the World Treats Bacter...

Seed
14 employees
Agriculture, Biotechnology
Phage Pharm vs
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. United Kingdom

Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance with engine...

Venture round
10 employees
Biopharma, Biotechnology
Phage Pharm vs
Gachun Biotech
Gachun Biotech

A pioneering platform specializing in the industrialization of pharmaceutical intermediates and APIs

Series A
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Phage Pharm

Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
Phage Pharm was founded in 2017.
Phage Pharm operates in Biotechnology, Manufacturing and Pharmaceutical.
Phage Pharm has completed 1 funding round, raising a total of $90.00M. The latest funding stage is Series B.
Top alternatives and competitors to Phage Pharm include Omnilytics Inc, Phico Therapeutics Ltd., Gachun Biotech, Bayer, LIVZON PHARMACEUTICAL GROUP INC.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phage Pharm and Omnilytics Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phage Pharm, https://bouncewatch.com/company/phage-pharm, updated 11 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes